Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06662435 · ClinicalTrials.gov registry record · NA
GYNecologic Cancer-Related COGnitive Impairment
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT06662435 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 60 participants.
The verdict
NCT06662435, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.
Interventions
- BEHAVIORAL GYNCOG
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-02-07 |
| Est. Completion | 2026-03-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06662435
The ClinicalTrials.gov registry entry for NCT06662435 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GYNCOG is the first listed.
NCT06662435 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06662435 about?
NCT06662435 is a clinical study titled "GYNecologic Cancer-Related COGnitive Impairment". The goal of this study is to test a home-based and patient-tailored cognitive training intervention among gynecologic cancer patients who have completed chemotherapy and who have experienced cancer-related cognitive impairment.
What is the current status of trial NCT06662435?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2025-02-07. Estimated completion is 2026-03-20.
What interventions are being tested in trial NCT06662435?
The interventions under investigation include: GYNCOG (BEHAVIORAL).
Who is sponsoring clinical trial NCT06662435?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.